06/07/2024
4:01 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form S-8 POS | |
06/07/2024
4:04 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form S-8 POS | |
06/07/2024
4:07 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form S-8 POS | |
05/14/2024
12:53 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
5:07 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form DEFA14A | |
04/22/2024
12:53 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form ARS | |
04/22/2024
12:37 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form DEFA14A | |
|
04/22/2024
12:13 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form DEF 14A | |
03/27/2024
3:26 PM | Avidity Partners Management LP (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
| Form SC 13G | |
03/12/2024
8:33 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:50 PM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Mahal Jeetinder Singh (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
4:49 PM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Lis William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
3:52 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/04/2024
6:40 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
6:27 PM | CROSS HERB (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
6:31 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
6:33 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
MARTELL RON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
6:22 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Tucker Edwin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:18 PM | CITADEL ADVISORS LLC (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
02/14/2024
8:41 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
02/12/2024
5:00 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
02/12/2024
5:23 PM | Abingworth Bioventures VII LP (Reporting)
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:36 PM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Velan Capital Investment Management LP (Filed by)
| Form SC 13D/A | |
02/09/2024
7:40 PM | Avego Healthcare Capital Holdings, LLC (Reporting)
Avego Healthcare Capital, L.P. (Reporting)
Avego Management LLC (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Morgan Adam (Reporting)
Velan Capital Holdings LLC (Reporting)
Velan Capital Investment Management LP (Reporting)
Velan Capital Management LLC (Reporting)
Velan Capital Master Fund LP (Reporting)
VENKATARAMAN BALAJI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
8:07 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
8:15 AM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G/A | |
02/02/2024
8:50 AM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
01/04/2024
5:04 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
7:05 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
5:06 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
7:14 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
WIGGANS THOMAS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:11 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form DEF 14A | |
11/09/2023
3:01 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form PRE 14A | |
11/09/2023
8:18 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
7:05 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
4:58 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
WIGGANS THOMAS G (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
5:00 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
WIGGANS THOMAS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
7:00 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
5:04 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
5:55 PM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Lis William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/13/2023
5:56 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Lis William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Top 5 Tech Stocks to Buy for 2024 (Ad) The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", |
10/13/2023
5:57 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
MARTELL RON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
5:58 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
10:15 AM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G | |
10/10/2023
6:00 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
5:19 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:14 PM | CROSS HERB (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/26/2023
3:16 PM | CROSS HERB (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
7:00 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
7:05 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
3:05 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
3:06 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/20/2023
8:47 PM | Brun Scott C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2023
8:48 PM | Brun Scott C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
8:09 PM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Mahal Jeetinder Singh (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
7:45 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Tucker Edwin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
7:54 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
7:45 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Tucker Edwin Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
